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Trace amines produced by skin bacteria accelerate
wound healing in mice
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Paula Maria Tribelli1,6,7, Kay Nieselt 4, Dewi Hidayati2✉ & Friedrich Götz 1✉
Certain skin bacteria are able to convert aromatic amino acids (AAA) into trace amines (TA)
that act as neuromodulators. Since the human skin and sweat contain a comparatively high
content of AAA one can expect that such bacteria are able to produce TA on our skin. Here
we show that TA-producing Staphylococcus epidermidis strains expressing SadA are pre-
dominant on human skin and that TA accelerate wound healing. In wounded skin, kerati-
nocytes produce epinephrine (EPI) that leads to cell motility inhibition by β2-adrenergic
receptor (β2-AR) activation thus delay wound healing. As β2-AR antagonists, TA and
dopamine (DOP) abrogate the effect of EPI thus accelerating wound healing both in vitro and
in a mouse model. In the mouse model, the S. epidermidis wild type strain accelerates wound
healing compared to its ΔsadA mutant. Our study demonstrates that TA-producing S.
epidermidis strains present on our skin might be beneficial for wound healing.
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Trace amines (TA) and classical neurotransmitter (dopa-mine, norepinephrine, or serotonin) are stored andreleased together in and from the nerve terminals1,2. TA
play crucial roles physiologically as neuromodulators of synaptic
transmission of classical neurotransmitter in mammalian brain by
potentiating their activity3,4. Beside acting as neuromodulator,
TA are reported to interact with a new family of G protein-
coupled receptors (GPCRs), the TA-associated receptors
(TAARs), thus they act independently from classical neuro-
transmitter5,6. Borrowsky and colleagues reported that pheny-
lethylamine (PEA) and tyramine (TYM) modulate the synaptic
excitation of dopaminergic neurons or alter the reactivity of
dopamine D2 receptor (D2R) to ligands by activating TAAR15,7.
It has also been reported that TA interacts with various adre-
nergic receptors (ARs). TA act as agonists on α2-adrenergic
receptor (α2-AR)8–10 and as partial allosteric antagonists on β2-
adrenergic receptor (β2-AR)11.
Recently, it has been shown that various species of the genus
Staphylococcus are able to produce TAs by using an enzyme
called SadA (staphylococcal aromatic amino acid (AAA)
decarboxylase)8. SadA is highly promiscuous because it not only
decarboxylates all biogenic AAAs into tryptamine (TRY), PEA,
and TYM but also dihydroxy phenylalanine (L-DOPA) and 5-
hydroxytryptophan (5-HTP) to the neurotransmitter dopamine
(DOP) and serotonin (SER).
First, it was not clear what might be the advantage to the
bacteria of having SadA. The AAAs present in the medium are
imported into the cell, pyridoxal phosphate (PLP)-dependent
decarboxylated, and quantitatively excreted into the medium as
TA8. There is no evidence that AAAs are used for protein bio-
synthesis or are involved in other metabolic pathways. Since
energy-consuming reactions rarely occur in nature without a
reason, the question arises as to what is the benefit of TA
synthesis to the bacteria. As many TA-producing staphylococcal
species are described as animal pathogens and skin colonizers,
comparative studies with Staphylococcus pseudintermedius and its
sadA deletion mutant were carried out. S. pseudintermedius is
responsible for severe and necrotizing infections in humans and
dogs12–14. Staphylococci are part of the human intestinal
microflora and the TA-producing staphylococci are predominant
among the staphylococcal genus present8. One reason for the
predominance of TA-producing staphylococci in the gut could be
that TA increase the internalization of bacteria into the host
cells8. It is well documented that an increase in internalization of
the epithelial cells protects the bacteria from both the host
immune system15–17 and antibiotics18,19.
The molecular mechanism of how these neurochemicals boost
bacterial internalization has been unraveled only recently20. TA
ad DOP activate α2-AR and induce a reduction of the cyto-
plasmic cAMP level as well as an increased F-actin formation.
This causes an increased internalization of the bacteria by the
host cells. This internalization mechanism is independent from
the FnBP-Fn-α5β1 integrin-mediated pathway20. The TA-
triggered internalization of bacteria into the host cells repre-
sents a new invasion mechanism. The additional role of TA-
producing bacteria play in the gut is unknown and such role is
difficult to verify. However, in the meantime it emerged that
neurotransmitters and neuromodulators are not only produced
by the host, but also by the gut microbiota and that they play a
role in the Gut-Brain axis21.
Here we show that TA produced by skin bacteria accelerate
wound healing by antagonizing the EPI-induced cell migration
inhibition.
Results
TA-producing Staphylococcus epidermidis strains are pre-
dominant on human skin. Since TA-producing staphylococci
have an advantage in host cell adherence and internalization8, we
investigated whether and how many TA-producing staphylococci
colonize the human skin and its prevalence. We took skin
swabs from the forearm (antecubital fossa) of 28 healthy volun-
teers as illustrated in Supplementary Fig. 1. The swabs were
examined for the presence of staphylococci using SK-salt agar, a
selective medium for isolating coagulase-positive and coagulase-
negative staphylococci22. All volunteers were colonized with
staphylococci with the degree of colonization varied from 5 to
6000 CFU/100 cm² (Fig. 1a). Twenty out of 28 volunteers were
colonized by TA-producing staphylococci (70%) (Fig. 1b). In total
we isolated 900 colonies and tested them for TA production by
Fig. 1 TA-producing S. epidermidis is prevalent on human skin. a Number of staphylococci (CFU/100 cm²) found on the forearm (antecubital fossa) of 28
volunteers. b 900 random colonies from all volunteers were assayed by HPLC analysis for TA production: 70% of the volunteers carried TA producing
staphylococci. c Of the 900 colonies, 185 (20%) produced TA; these colonies were identified at species level using 16s rRNA sequencing. The majority of
TA producer belonged to S. epidermidis, followed by S. capitis, S. haemolyticus, and S. caprae.
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HPLC analysis (Supplementary Fig. 2). Of the 900 staphylococcal
colonies/strains 185 produced TA (20%) as shown in Table 1. We
identified all of 185 TA producer using 16S rRNA sequencing.
The majority of the TA-producing staphylococci belonged to
S. epidermidis (92,8%) followed by S. capitis, S. haemolyticus, and
S. caprae (Fig. 1c).
We also asked how prevalent the sadA gene is in the S.
epidermidis species and blasted (tblastn of NCBI’s Microbial
BLAST) the SadA protein sequence of ATCC 12228 against 19
complete S. epidermidis genomes. 11 of the genomes (58%)
encoded a highly homologous (99–100% identity) SadA protein,
while other staphylococcus species, such as of S. pseudintermedius
ED99 shared only 52% identity (Table 2).
TA and DOP abrogate the EPI-induced cell migration arrest—
thus accelerating the wound healing. Given that human skin
cells, particularly keratinocytes, express β2-adrenergic receptor
(β2-AR)23–26, whereas TYM and PEA are allosteric antagonists
for β2-AR11, we asked whether the TA produced by sadA-
expressing staphylococci promote skin wound healing.
To address this question, we first carried out an in vitro
migration assay with HaCaT cells, a human keratinocyte cell line
that expresses β2-AR27. It is well known that the stress hormone
epinephrine (EPI) acts as an agonist of the β2-AR, which lowers
the migratory rate of keratinocytes and thus impairing wound
healing28,29. We wanted to find out if TA and DOP, as agonists of
the alpha2-adrenergic receptor (α2-AR)20, are able to abrogate
the EPI effect. The wound healing assay was carried out in the
presence of EPI (25 μg/ml) alone and in combination with TA
(TRY, PEA, TYM) and DOP (each at 25 μg/ml). We included
DOP in the experiment since the sadA-expressing staphylococci
can also convert L-DOPA into DOP8. As a further control we
included ICI 118551 (ICI), a selective β2-AR antagonist, also
referred to as beta blocker30. For better comparison we used for
all compounds at the same concentration of 25 μg/ml. At this
concentration the effect of EPI on gap closing in HaCaT cells was
most pronounced (Supplementary Fig. 3a).
The in vitro wound healing assay, which is mainly based on the
determination of the host cell migration rate, was performed with
HaCaT cells in culture-insert (2-wells format). In comparison to
the control (untreated cells), EPI visibly delayed gap closing by
lowering the migration of HaCaT cells. However, in the presence
of TRY, PEA, TYM, DOP or ICI, the negative effect of EPI was
abrogated and gap closing was almost as efficient as the control
(Fig. 2a). The positive effect of ICI was mainly due to its inverse
agonist effect on ß-AR31,32. The gap closing analyses using
ImageJ showed that TA and DOP abrogated (p < 0.05) the
negative effect of EPI on gap closing (Fig. 2b). In the absence of
EPI, no effect on gap closing was seen with TA, DOP and ICI in
comparison to the control (Fig. 2c). We also tested alprenolol
(ALP, a neutral ß2-AR), which showed similar effect as ICI
(Fig. S3b). Phentolamine (PTL) showed no effect in gap closing
suggesting that α-AR does not play a role in gap closing of
HaCaT cells (Supplementary Fig. 3b).
TA and DOP enhance the migration of HaCaT cells even in the
presence of mitomycin C. Wound healing involves two distinct
mechanisms, cell proliferation and cell migration. Therefore, we
investigated cell migration and cell proliferation independently.
Cell migration assay was carried out with HaCaT cells as
described earlier, with the only difference that we added mito-
mycin C (10 μg/ml) to inhibit the cell proliferation.
In the absence of mitomycin C the gap closing was about 85%
after 24 h (Fig. 2b, control). However, in the presence of
mitomycin C, however the gap closing in the control decreased
to only 15% after 24 h (Fig. 3a). In the presence of EPI gap closing
decreased further to only 5%, while the addition of TA, DOP, and
ICI abrogated the negative effect of EPI (Fig. 3a). In the presence
of mitomycin C and the absence of EPI, TA, and DOP showed a
similar gap closing as observed in the control (Fig. 3a, second
half). In the presence of ICI, the gap closing was always higher.
Here we show that the inhibition of cell proliferation by
mitomycin C decreased the gap closing but had no principal
effect on the activities of TA, and DOP, indicating that TA and
DOP only affect cell migration but not proliferation.
TA and DOP counteract the EPI-induced activation of β2-AR.
Activation of the β-AR by EPI inhibits the wound closing by
inhibiting the migration of keratinocytes29,33–35. Since the acti-
vation of β-AR is followed by an increase in the intracellular
cAMP level which decreases cell migration, we investigated
Table 1 Harvested staphylococcal colonies per volunteer and distribution of TA producers.
CFU range of staphylococci on
volunteers’ skin (CFU/100 cm2)
Harvested colonies analyzed for
TA production by HPLC




>1000 120 1, 3, 4 360 185= 20%
500–1000 60 14, 20, 26, 23 240
200–500 30 5, 18, 19, 22, 25, 27 180
50–200 15 7, 9, 12, 17, 21, 28 90
0–50 ≤7 2, 6, 8, 10, 11, 13,
15, 16, 23
30
Table 2 Presence and identity of SadA in S. epidermidis.
S. epidermis strains SadA identity in %
O47 + 100










ATCC 14990 − –







S. pseudintermedius ED99 + 52
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whether TA, DOP, and ICI can counteract this activity. Indeed, in
the presence of EPI alone, the relative cAMP level was increased
by approximately 50% compared to the control, while the addi-
tion of TA, DOP, and ICI caused a decrease (p < 0.01) in the
cAMP level (Fig. 3b).
In contrast, the relative F-actin level, which positively
correlates to the migration36, was decreased by the addition of
EPI and this effect was partially abrogated by TA and DOP
(Fig. 3c). In the absence of EPI, TA, and DOP showed no effect
on cAMP and F-actin level, while ICI decreased the cAMP level
and increased the F-actin significantly (p < 0.01) compared to the
control. This is due to the inverse agonist effect of ICI31,32
(Supplementary Fig. 4a, b). As expected, in the presence of the
β-AR blocker, ICI, the effect of EPI was almost completely
abrogated. Our data show that TA and DOP are only able to
partially abrogate the EPI effect.
TA and DOP affect neither effect cell proliferation nor intra-
cellular Ca++ level. We performed HaCaT proliferation assay in
the presence of EPI (25 μg/ml) alone and together with TA, DOP,
and ICI (each at 25 μg/ml). EPI alone caused an increase in cell
proliferation by about 50%. The addition of TA and DOP to the
EPI treated cells had no effect (Fig. 4a). TA and DOP showed no
difference to the control level in the absence of EPI (Fig. 4a,
second half).
Fig. 2 TA and DOP accelerate wound healing in vitro in a wound-mimicking assay. a TA and DOP (each at 25 μg/ml) were added into the HaCaT cell
culture seeded with a gap in the presence of EPI (25 μg/ml). ICI 118551 was used as positive control. Microscopic images of the gaps were taken at time 0
h and 24 h. b The gap closing, which was calculated using ImageJ67, revealed that TA and DOP abrogated the migration-inhibiting effect of EPI. c In the
absence of EPI, the TA, DOP and ICI showed similar gap closing as control. Each data point is the mean value ± SEM from 4 independent replicates for
(b) and 3 independent replicates for (c), *p < 0.05; **p < 0.01; and ***p < 0.001, data were analyzed using Student's t test. Source data are provided as a
Supplementary Data 1 file.
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Considering that one of the factors that regulate the cell
proliferation is intracellular Ca++ level37–39 we investigated the
potential effect of TA and DOP on intracellular Ca++ level.
As shown in Fig. 4b, EPI increased the intracellular Ca++ level
after 3 min, whereas the addition of TA and DOP did not alter the
Ca++ level. Only the ß-blocker ICI decreased the Ca++ level to
the control value (Fig. 4b). The lack of responsiveness of TA and
DOP to cell proliferation and the intracellular Ca++ level in the
presence of EPI confirms that TA and DOP do not affect cell
proliferation. In the absence of EPI, the Ca++ level was not
affected by TA, DOP, and ICI (Supplementary Fig. 4c).
These results show that EPI impairs wound healing (gap
closing) in keratinocytes and that TA and DOP abrogate the
effect of EPI. Furthermore, the effect of the TA and DOP is not
based on cell proliferation but rather on cell migration.
TA and DOP produced by skin staphylococci accelerate the
wound healing in a murine model. Our next question was
whether the positive effect of TA and DOP on wound healing can
also be observed in vivo. It is well known that one of the stress
responses to the wound is the systemic and local increase of EPI,
which impairs wound healing40,41. Therefore, we investigated the
effect of TA, DOP, and ICI on wound healing in a murine model.
Cutaneous wound healing experiments were performed in DDY
mice with two circular full-thickness wounds on the back of each
mouse. Each mouse was treated both on one side with TA or
DOP and the other side with water as control starting from day 0
post-wounding. ICI was used as a positive control. The wound
diameter was measured by calculating the mean of diameters
measured from two sides of one wound (Supplementary Fig. 6).
This procedure was chosen because the wound area was not
always circular. The wounds treated with TA, DOP or ICI (25 μg/
ml) closed faster than the controls (Fig. 5a and Supplementary
Fig. 4). This confirms that the positive wound healing effect
observed with keratinocytes also applies for the mouse model.
To mimic the natural condition where TA-producing staphy-
lococci and AAA are present on the skin, we applied S.
epidermidis O47 as a model for skin staphylococci on the wound
murine model with the application of phenylalanine. It resulted
that wounds with S. epidermidis O47 wild type closed faster than
wounds with S. epidermidis O47 ΔsadA (Fig. 5b). This result
suggests that the TA-producing skin staphylococci play a role in
accelerating wound healing.
Discussion
The fact that many staphylococcal species are able to produce TA
with the help of the enzyme SadA is a new insight8. Originally, we
investigated the occurrence of TA-producing staphylococci in the
gut of human volunteers and found that the TA-producing
strains were predominant among the isolated staphylococcal
strains. This finding suggests that such strains most likely have an
advantage, which to this time is unclear.
Here we addressed the question whether TA-producing sta-
phylococci are prevalent on our skin and what effect TA pro-
duction has for our skin. The skin is a classical habitat for
members of the Staphylococcacea as already described by Kloos
Fig. 3 TA and DOP partially abrogate the effect of EPI in inhibiting HaCaT cells migration by affecting cAMP level and F-actin formation. a HaCaT cells
migration was examined using a similar method as the wound healing assay with the addition of Mitomycin C (10 µg/ml). TA, DOP and ICI (25 µg/ml)
enhanced the HaCaT cells migration in the presence of EPI (25 µg/ml). TA and DOP alone did not show any significant effect while ICI boosted the
HaCaT cells migration. b HaCaT cells was incubated with EPI (25 µg/ml) and TA, DOP and ICI as positive control (25 µg/ml) separately for 2 h. TA, DOP
and ICI were added 30min prior to the addition of EPI. EPI increased the intracellular cAMP level of HaCaT cells but the addition of TA, DOP and ICI,
decreased the cAMP level compared to HaCaT cells treated with EPI alone. c EPI (25 µg/ml) decreased the F-actin level compared to the control. The
addition of TA, DOP and ICI (25 µg/ml) in the presence of EPI, increased the F-actin level compared to the treatment with EPI only. For all graphs, each
data point is the mean value ± SEM from 3 independent replicates for (a) and from 6 independent replicates for (b), *p < 0.05; **p < 0.01, data were
analyzed using Student's t test. Source data are provided as a Supplementary Data 1 file.
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and Schleifer. The authors mapped and characterized the sta-
phylococcal species on human skin42,43, and presented a body
atlas with the distribution of live staphylococcal species on var-
ious regions of the adult skin44. They already described that
staphylococci, coryneforms, micrococci, and bacilli were the most
predominant and persistent bacteria isolated from the head, legs,
and arms. Later characterizations using genomic approaches
revealed a much greater diversity of bacteria than that by the
culture-based methods, but nevertheless, they come to a similar
topographical distribution of bacteria on skin sites45,46. Due to
the high abundance of staphylococci on the skin, we choose to
take samples from the forearm (antecubital fossa) of 28 volun-
teers and plated them on a staphylococcal selective SK-salt agar.
20% of the 900 isolated staphylococcal colonies produced TA and
the majority belonged to S. epidermidis, a species in which we
found that >50% of the strains carried the sadA gene.
The key question in this study was whether TA can be pro-
duced by the skin bacteria and if so, the possible role they play on
the skin. In staphylococci, we have found that TA are produced if
the environment contains AAAs. There is no evidence that AAA
are used for protein biosynthesis, instead they are imported,
decarboxylated by SadA and excreted as TA8. Therefore, TA
should be produced if sufficient AAAs are present on the skin.
This is indeed the case as human sweat contains a comparatively
high content (in the range of 300 μM or about 60 μg/ml) of
AAAs47–51. In this context, approximately 10 μg/100 cm2 of AAA
and 5 μg/100 cm2 of TA can be detected on our skin
(Supplementary Table 1). For this reason, it is expected that
sadA-expressing staphylococci are able to produce TA on our
skin. During the course of the investigation of the possible role
TA–DOP–ICI might play on our skin, we found out that they
accelerate wound healing.
After an injury, keratinocytes migrate over the wound bed to
repair a wound. However, a wound triggers a stress reaction that
leads to the production of various stress hormones such as EPI
and cortisol which delay wound healing28,29,41. The enzymes
necessary for both cortisol and EPI synthesis are located in the
epidermis. Keratinocytes synthesize both hormones locally41,52,53.
Keratinocytes also express beta-2-adrenergic-receptor (ß2-AR), a
receptor for the stress hormone EPI, also known as adrenaline.
Local cortisol and EPI synthesis impair keratinocyte migration
and delay re-epithelialization52,54. Activation of β2-AR inhibits
keratinocyte migration in a cAMP-independent manner55, while
antagonists of the ß2-AR accelerate wound healing56. The con-
centration of EPI that we used (25 μg/ml = 136 μM) is above the
physiological concentrations found in plasma of mice with a
wounded skin (18 ng/ml or 0.1μM)41. However, it could be that
HaCaT cells express lower concentrations of ß2-AR. If this is the
case, they would need a higher concentration of ligands to be
responsive. On the other hand, we show in our mouse model
(with the endogenously produced EPI) the effectiveness of TA.
The interaction of TA with the TA-associated receptors
(TAARs), suggests that TA may also have functions that are
entirely independent of the classical neurotransmitters5,6. Indeed,
in co-stimulation studies have found that TYR and PEA are partial
allosteric antagonists of ß1- and ß2-AR11. However, if TA are ß2-
AR antagonists, then they should also accelerate wound healing.
To analyze the impact of TA–DOP–ICI on wound healing we
have chosen two classical approaches. We carried out an in vitro
migration or wound healing assay with HaCaT cells, a human
keratinocyte cell line that expresses β2-AR27. In the presence of
EPI, TA–DOP–ICI accelerated gap closing (p < 0.05) (Fig. 2a, b).
No effect of TA–DOP–ICI was observed in the absence of EPI
(Fig. 2c).
It is important to discriminate between the effect of pro-
liferation and migration of adjacent cells on wound closure.
Therefore, we investigated the wound healing of HaCaT cells in
the presence of mitomycin C, a potent DNA crosslinker and
inhibitor of cell proliferation. Comparison of Fig. 2 and Fig. 3
shows that in the presence of mitomycin C the gap closing was
generally decreased from 85% to about 15%. However, indepen-
dent of the presence or absence of EPI, TA–DOP–ICI always
increased gap closing to almost the control level (Fig. 3a).
These result show two things: firstly, EPI worsens wound
healing in the presence of mitomycin C. In addition to the
inhibition of cell proliferation by mitomycin, cell migration is
now inhibited by EPI. Similar effects were reported for catecho-
lamines (isoproterenol, EPI, and norepinephrine), which delay
wound closure by inhibiting epidermal cell migration57. Secondly,
TA–DOP–ICI counteracted the negative effect of EPI on gap
closing, indicating that they activate cell migration.
To further confirm that TA–DOP–ICI abrogate the negative
effect of EPI on cell migration, we investigated the cAMP and F-
actin levels in cytoplasm. It has been the accepted dogma since the
1960s that β2-receptor activation causes an increased intracellular
cAMP levels due to the stimulation of adenylate cyclase58,59. As
expected, EPI increased the plasma cAMP level in HaCaT cells,
and this increase was counteracted by TA–DOP–ICI, indicating
that they antagonize the EPI effect (Fig. 3b). Similar effect was
observed with F-actin (Fig. 3c). EPI decreased the F-actin level,
while TA–DOP–ICI relieved this blockade. The EPI-induced
decrease of the F-actin level is responsible for the inhibition of cell
migration.
Fig. 4 TA and DOP did not inhibit the HaCaT cell proliferation and the
increase of intracellular Ca++. a HaCaT cells proliferations were
measured using MTT assay. The presence of EPI (25 µg/ml) increased the
cell proliferations compared to control. The addition of TAs and DOP (25
µg/ml) showed no significant effect. b The intracellular Ca++ was
measured using fluorescence-based assay. HaCaT cells was incubated in
the presence of EPI (25 µg/ml) alone, and EPI with TA, DOP, and ICI. EPI
increased the intracellular Ca++ level with and without TA and DOP at 3
min ICI nullified the effect of EPI both in terms of cells proliferation and
increase in intracellular Ca++. For all graphs, each data point is the mean
value ± SEM from three independent replicates, *p < 0.05; **p < 0.01; and
***p < 0.001, data were analyzed using Student's t test. Source data are
provided as a Supplementary Data 1 file.
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It has been reported that EPI stimulates cell proliferation60 and
increases the intracellular calcium level61. Therefore, we tested
TA–DOP–ICI whether they negate EPI's activity on cell pro-
liferation and intracellular calcium level (Fig. 4a, b). However,
there was no such activity observed, indicating that TA–DOP are
not involved in cell proliferation. In our studies, ICI was also
included as a control since it is a selective ß2-AR antagonist or
beta blocker31. Its effect to counteract EPI-induced activation of
ß2-AR was always stronger than that of TA–DOP, suggesting that
ICI is a full ß2-AR antagonist, while TA–DOP are partial
antagonists.
As all these studies were done in vitro with keratinocytes we
examines the activity of TA–DOP in vivo using a mouse model.
In agreement with in vitro studies, the wound healing was
accelerated by TRY, DOP, PEA, TYM, and ICI (p < 0.05) (Fig. 5a
and Supplementary Fig. 5).
Cogen et al. 62 stated that skin microbiota are usually regarded
as pathogens, potential pathogens or innocuous symbiotic
organisms. Indeed, it has long been assumed that a normal skin
microbiota has rather a protective rather than destructive function
on our skin. For example, a commensal strain of S. epidermidis
protects again skin neoplasia63. Here we show that the TA pro-
duced by skin bacteria accelerate wound healing (Fig. 5b). A
wound represents a stress situation which is accompanied by the
production of various stress hormones such as EPI and cortisol
which delay wound healing by inhibiting cell migration due to
activation of ß2-AR. Members of Staphylococcaceae, particularly
the classical skin bacterium S. epidermidis, produces TA, which act
as neurotransmitter or neuromodulators. While studying the
function of TA on our skin, we found that they abrogate the
negative effect of EPI on wound healing thus accelerate wound
healing. Surprisingly, when we applied the S. epidermidis strains
2 days post-wounding at and around the wound area, 95% of the
mice showed no infection symptoms such as inflammation or
necrosis, suggesting that commensal S. epidermidis strains evolved
strategies to co-exist rather than being a symbiote on our skin.
Methods
Skin swab samples collection, sadA-expressing staphylococci screening and
AAA and TA quantification of skin swab samples. We collected the skin swab
samples from 28 healthy and random subjects by swabbing the antecubital fossa
part using sterile swab sample collector and sterile phosphate buffer saline (PBS).
Fig. 5 Effect of TA on wound healing in mice.Mice were shaved and wounded on their back with 2 biopsy punches for each mouse. a TRY, PEA, TYM, and
DOP (each 25 μg/ml) with total volume of 10 μl were applied topically daily starting from day 0. The diameter of the wounds was measured every 2 days.
The wounds treated with TRY, PEA, TYM, and DOP showed a faster wound closing than the untreated wounds (control). b S. epidermidis O47 WT and
ΔsadA were applied on and around the wound at cell density 5000 CFU/100 cm2 on 2 days post-wounding (green arrow). In addition, 10 μl phenylalanine
(Phe) 50 μg/ml was also applied daily. The diameter of the wounds on 2 days post-wounding before application of S. epidermidis O47 were not significantly
different. Wounds treated with S. epidermidis O47 WT showed faster wound closure than those treated with S. epidermidis O47 ΔsadA. For all graphs, each
data point is the mean value ± SEM from three independent replicates for (a) and six independent replicates for (b), *p < 0.05 and **p < 0.01, data were
analyzed using paired Student's t test. Source data are provided as a Supplementary Data 1 file.
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Collected skin swab samples were then spread on SK salt agar medium8 and
incubated at 37 °C for 48 h. The colonies were then picked, inoculated in basic
medium (BM) in 96-well plates and incubated at 37 °C for 24 h with shaking at
150 rpm. The collected supernatants were analyzed by reversed-phase HPLC (RP-
HPLC) at room temperature with an Eclipse XDB-C18 column (4.6 × 150 mm;
5 μm) (Agilent) installed together with an analytical guard column for Eclipe XDB-
C-18 (4.6 × 12.5 mm; 5 μm) (Agilent), with a 15-min linear gradient of 0.1%
phosphoric acid to acetonitrile and 5 min post time washing with 0.1% phosphoric
acid. The flow rate used was 1.5 mL/min; the sample volume that was injected was
10 μl. We used diode array detector (DAD) at 210 nm and 360 nm as reference.
The simplified workflow is illustrated in Fig. S1. While for AAA and TA quanti-
fication on skin swab samples, we resuspended the samples in sterile PBS and
analyzed using RP-HPLC with the same method as for screening.
Skin staphylococci identification. We identified the species of the isolated TA
producing staphylococci by growing the strains on the selective agar separately and
incubated overnight at 37 °C. We then picked the colonies, resuspended in PBS and
isolated the genomic DNA using Quick-DNA Microprep Kit (Zymo Research). We
then amplified the 16s rRNA gene using specific primers (Supplementary Tabel 1)
and Q5 polymerase (New England Biolabs). We purified the PCR product using
Illustra GFX DNA and Gel Band Purification Kit (GE healthcare) and sequenced it
(GATC). We identified the species by performing BLASTN from the obtained
sequence of amplified 16s rRNA gene against the 16s rRNA database in NCBI.
Construction of sadA deletion mutant in S. epidermidis O47. Construction of S.
epidermidis O47 ΔsadA was carried out using plasmid pBASE664. The 1 kb
upstream downstream region of sadA were amplified using appropriate primers
(Supplementary Table 2) and ligated with linearized pBASE6 (EcoRV restriction
site) using Hi-Fi DNA Assembly Master Mix (New England Biolabs) and trans-
formed into E. coli C2987 (New England Biolabs) and then into E. coli DC10B
chemically competent cells. Colonies with the desired plasmid were picked and the
respective plasmid was transformed into S. epidermidis O47 by protoplast trans-
formation. Mutagenesis was conducted as reported by65. Mutants were confirmed
using PCR for the gene deletion and HPLC analyses for the overnight supernatants.
Bioinformatic analysis. Homologs of SadA from S. pseudintermedius ED99 were
identified within the species S. epidermidis. To find homologs on the strain level
tblastn of NCBI’s Microbial BLAST was used and all complete genomes of S.
epidermidis were used as a database. As a query the SadA homolog of the S.
epidermidis strain ATCC 12228 (NC_004461.1, genomic position 107418-108839)
was used as a query sequence.
In vitro wound healing assay with HaCaT cells. The in vitro wound healing assay
with HaCaT cells was carried out essentially as described by Jonkman et al.66
HaCaT cells were seeded in culture-insert 2 well in μ-dish35 mm,low (Ibidi) with a
cell density 6 × 105 cells/ml and in 70 μl volume in DMEM medium with 10% fetal
bovine serum (FBS) and antibiotic mix and incubated at 37 °C in 5% CO2 for 24 h
prior to the assay. After 24 h incubation, the culture-inserts were gently removed,
and the cell culture was washed with PBS twice and 1 ml of DMEM medium was
added into the μ-dish. Gap closing was microscopically monitored (Leica DMLB)
with ×100 magnification (×10 objective lens and ×10 ocular lens magnification).
The TA, DOP and ICI were added at a concentration of 25 μg/ml each and
incubated for 30 min prior to the addition of EPI (25 μg/ml). Cell cultures were
then incubated for 24 h and microscopic images were taken. The gaps were ana-
lyzed using ImageJ as described in ref. 67 and wound closing was calculated by
subtracting the final gap area from initial gap area. Cell migration assays were
carried out in a similar way as described for the in vitro wound healing assay, but
10 μg/ml of Mitomycin C was added as a cell proliferation inhibitor. We performed
at least three times independent replications for each experiments.
Cell proliferation assay. Prior to the cell proliferation assay, HaCaT cells were
seeded in a 96-well microtiter flat-bottom plate with 5 × 104 cells/well and incu-
bated 24 h at 37 °C in 5% CO2. The HaCaT cells were treated with the neuro-
chemicals (TRY, PEA, TYM, and DOP) and ICI 118155 at a final concentration of
25 μg/ml, with and without EPI (25 μg/ml). The cell proliferation assay was per-
formed using the Cell Proliferation Kit I (MTT; Roche, Germany) according to the
protocol provided by the company. We performed at least 3 times independent
replications for each experiment.
cAMP level measurement of HaCaT cells. Prior the cAMP measurement,
HaCaT cells were seeded in black 96-well plate flat bottom with 1 × 105 cells per
well and incubated overnight in DMEM medium with 10% FBS and antibiotic mix
and incubated at 37 °C in 5% CO2. Cells were then treated with TA, DOP and ICI
(25 μg/ml) for 30 min prior to the addition of EPI (25 μg/ml) and incubated further
for 1.5 h. cAMP levels were measured using cAMP GloTM Assay (Promega)
according to the protocol provided by the company. We performed at least 3 times
independent replications for each experiment.
F-actin level. Prior the cAMP measurement, HaCaT cells were seeded in black 96-
well plate flat bottom with 1 × 105 cells per well and incubated overnight in DMEM
medium with 10% FBS and antibiotic mix and incubated at 37 °C in 5% CO2. Cells
were then treated with TA, DOP and ICI (25 μg/ml) for 30 min prior to the
addition of EPI (25 μg/ml) and incubated further for 1.5 h. The treated cells were
then washed with DPBS, permeabilized with 0.1% (v/v) Triton X-100, washed
again with DPBS, stained with ActinGreen™ 488 ReadyProbes® (Thermo Fischer)
for 30 min and washed again 3–5 times with DPBS with soaking duration of 5 min
for each washing step. The relative fluorescence intensity was measured at 495 nm
for the excitation and 518 nm for the emission using Tecan Infinite M200. We
performed at least 3 times independent replications for each experiment.
Intracellular calcium assay. We seeded the HaCaT cells in 96-well microtiter flat
bottom plate with 5 × 104 cells/well and incubated for 24 h at 37 °C in 5% CO2. The
intracellular calcium measurement assays were performed using Fluo-8 calcium
flux assay kit—no wash (Abcam) according to the protocol provided by the
company. The HaCaT cells were treated with the neurochemicals (TRY, PEA,
TYM, and DOP) and ICI, with and without EPI. We performed at least 3 times
independent replications for each experiment.
In vivo murine model. For wound healing experiments we followed essentially the
protocol for cutaneous wound healing in a murine model as described Ganuli-
Indra68. Six to eight weeks old male of DDY mice were used in wound healing
experiments. Prior to the wounding, mice were anesthetized with ketamine/xyla-
zine (10:1) with a dose of 0.04 mg/g mouse weight. The back of the mice was
shaved and two circular full-thickness wounds (5 mm in diameter) were made on
the back skin of each mouse using a skin biopsy punch. Two wounds were made on
each mouse (right and left) so that the control and treatment were on the same
mouse. The neurochemicals TRY, PEA, TYM, and DOP as well as ICI 118551 at a
concentration of 25 μg/ml, respectively, and a total volume of 10 μl each were
applied topically on one wound (right), water was applied as control on the other
wound (left). The application of the neurochemicals was done daily, and the wound
diameters were measured every two days until 14 days post-wounding. We used
three mice for each variation in these experiments. For wound healing experiments
using bacteria, we used S. epidermidis O47 WT and its ΔsadA deletion mutant as
model bacteria. At two days post-wounding, we applied S. epidermidis O47 WT (on
the right wound) and ΔsadA (on the left wound) with a cell density of 5000 CFU/
100 cm2 at the wound area. At the same time, we applied phenylalanine (50 μg/ml)
with a total volume of 10 μl on wound daily. The wound diameters were measured
every two days until 14 days post-wounding. We used six mice in this experiment.
Statistics. Normal distributions were analyzed by Student’s t test. Statistical ana-
lyses were performed with GraphPad Prism software, with significance defined as
p < 0.05; n represents independent biological replicates.
Ethical statement. The collection of human skin swab samples was approved by
the Ethic Commission of the University of Tübingen (Approval no. 320/2017BO2).
Skin swab samples were obtained from 28 adult volunteers. All samples were
anonymized and obtained with written consent from the volunteers. The wound
healing experiment using mice were approved by the Ethic Commission of Faculty
of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia (Approval no.
2.KE.172.09.2019).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data are available from the authors upon request. The 16s rDNA sequences
are uploaded to NCBI with accession number MT445230-MT445414. Source data
underlying plots shown in figures are provided in Supplementary Data 1.
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